We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rising Diagnosis of Viral Meningitis Is Often Delayed

By LabMedica International staff writers
Posted on 10 Jul 2018
As the incidence of bacterial meningitis decreases, the proportion of meningitis cases caused by viruses is increasing and the use of molecular diagnostics has also led to increased recognition of neurological viral infections.

Identification of the cause of meningitis is important to improve clinical care, including reducing unnecessary use of antibiotics and antivirals. More...
Patients with suspected viral meningitis are often treated with antibiotics while a diagnosis of bacterial meningitis is excluded, which results in patients receiving long courses of antibiotics and can extend their hospital stay.

A large team of scientists working with the University of Liverpool (Liverpool, UK) carried out a multicenter prospective observational cohort study of adults with suspected meningitis at 42 hospitals across England. The investigators enrolled 1,126 patients were enrolled between September 30, 2011, and September 30, 2014. There were 638 (57%) patients who had meningitis: 231 (36%) cases were viral, 99 (16%) were bacterial and 267 (42%) had an unknown cause. 41 (6%) cases had other causes.

The team identified cerebrospinal fluid (CSF) samples with a leucocyte count of more than 4 × 106 cells/L from laboratory records and classified them according to pathogen identified (or unknown if none was found). All CSF samples were examined by microscopy and culture. CSF polymerase chain reaction (PCR) was done in the admitting hospitals, regional diagnostic centers, or the University of Liverpool, to test for herpes simplex virus types 1 and 2, varicella zoster virus, and enteroviruses, as well as Streptococcus pneumoniae and Neisseria meningitidis, following national recommendations. They applied a proportional inflation, based on the total number of cases (those recruited and those missed) divided by the actual number recruited into the northwest sites in the prospective study, to the initial estimated northwest incidence data.

The team found that found that diagnosis of meningitis was often delayed due to unnecessary brain scans being performed before lumbar puncture, which is the essential investigation to determine the cause of the illness. The majority of patients (81%) had a brain scan and 70% of those took place before lumbar puncture, otherwise known as a spinal tap. Overall, the specific virus or bacteria causing the illness was not identified for 43% of patients.

The authors concluded that their findings demonstrated that viruses are the predominant cause of adult meningitis in the UK, with enteroviruses and herpesviruses responsible for the majority of cases for which a cause is found. Michael Griffiths, BMedSci, BMBS, DPhil, a senior clinical lecturer and a co-author of the study, said, “Diagnosing a specific cause of meningitis quickly is key to getting patients on the right antibiotics, if needed, or avoiding unnecessary antibiotics in those with viral meningitis. Once viral meningitis has been diagnosed, efforts should focus on treatment of the symptoms and expediting discharge from hospital, which would be less distressing for patients and ease pressures on the NHS. The study was published on June 29, 2018, in the journal The Lancet Infectious Diseases.

Related Links:
University of Liverpool


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.